How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy

被引:55
|
作者
Quarmby, V
Quan, C
Ling, V
Compton, P
Canova-Davis, E
机构
[1] Genentech Inc, Dept Bioanalyt Technol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Analyt Chem, San Francisco, CA 94080 USA
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1998年 / 83卷 / 04期
关键词
D O I
10.1210/jc.83.4.1211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a significant systematic difference between the normal range obtained from ethylenediamine tetraacetate plasma samples using the Genentech total insulin-like growth factor I (IGF-I) RIA and normal ranges for other total IGF-I RIAs. To determine whether the quality of the assay standard was the cause of this systematic difference, we analyzed commercially available preparations of recombinant human IGF-I (rhIGF-I) typical of those used as IGF-I immunoassay standards along with our own well characterized rhIGF-I assay standard. For the commercial standards, high performance liquid chromatography-derived purities were low, and some vendor-assigned protein concentrations were inconsistent with values from quantitative amino acid analysis. The Genentech rhIGF-I assay standard was highly pure and quantitatively correct. However, the poor quality of some commercial rhIGF-I preparations was not the primary reason for the systematic discrepancy between the Genentech total IGF-I RIA normal range and most other normal ranges. Most assays for total IGF-I are calibrated against the WHO International Reference Reagent (IRR) for IGF-I Immunoassays (87/ 518). The Genentech total IGF-I RIA is not calibrated against WHO IRR 87/518. The protein content assigned to WHO IRR 87/518 was a consensus value from a multicenter collaborative study. Physicochemical analyses showed that WHO IRR 87/518 is Met(-1)-IGF-I of low purity (44%), and that the assigned protein content is higher than the value determined by quantitative amino acid analysis. Thus, assays that are calibrated against WHO IRR 87/518 will report total IGF-I concentrations in excess of actual values. We believe that calibration against WHO IRR 87/518 is the cause of the systematic discrepancy between the Genentech IGF-I assay normal range and most other normal ranges, and that much of the plasma IGF-I concentration data in the literature are of questionable accuracy.
引用
收藏
页码:1211 / 1216
页数:6
相关论文
共 50 条
  • [21] CHARACTERIZATION OF THE AFFINITIES OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEINS 1-4 FOR IGF-I, IGF-II, IGF-I/INSULIN HYBRID, AND IGF-I ANALOGS
    OH, Y
    MULLER, HL
    LEE, DY
    FIELDER, PJ
    ROSENFELD, RG
    ENDOCRINOLOGY, 1993, 132 (03) : 1337 - 1344
  • [22] COOPERATIVE PROPERTIES OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) RECEPTORS AND INSULIN/IGF-I HYBRID RECEPTORS IN TRANSFECTED CELLS
    CHRISTOFFERSEN, CT
    GRONSKOV, K
    GONZALES, N
    VISSING, H
    DEMEYTS, P
    DIABETES, 1993, 42 : A163 - A163
  • [23] Stimulation of the development of bovine embryos by insulin and insulin-like growth factor-I (IGF-I) is mediated through the IGF-I receptor
    Matsui, M
    Takahashi, Y
    Hishinuma, M
    Kanagawa, H
    THERIOGENOLOGY, 1997, 48 (04) : 605 - 616
  • [24] Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by IGF-I and basic fibroblastic growth factor
    HernandezSanchez, C
    Werner, H
    Roberts, CT
    Woo, EJ
    Hum, DW
    Rosenthal, SM
    LeRoith, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) : 4663 - 4670
  • [25] Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels
    Johansson, Mattias
    Mckay, James D.
    Wiklund, Fredrik
    Rinaldi, Sabina
    Verheus, Martijn
    van Gils, Carla H.
    Hallmans, Goran
    Balter, Katarina
    Adami, Hans-Olov
    Gronberg, Henrik
    Stattin, Paer
    Kaaks, Rudolf
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12): : 4820 - 4826
  • [26] INSULIN-LIKE GROWTH FACTOR-I (IGF-I) ATTENUATION OF GROWTH-HORMONE IS ENHANCED BY OVEREXPRESSION OF PITUITARY IGF-I RECEPTORS
    YAMASAKI, H
    PRAGER, D
    GEBREMEDHIN, S
    MELMED, S
    MOLECULAR ENDOCRINOLOGY, 1991, 5 (07) : 890 - 896
  • [27] INSULIN-LIKE GROWTH FACTOR-I (IGF-I)-BINDING PROTEIN COMPLEX IS A BETTER MITOGEN THAN FREE IGF-I
    BLUM, WF
    JENNE, EW
    REPPIN, F
    KIETZMANN, K
    RANKE, MB
    BIERICH, JR
    ENDOCRINOLOGY, 1989, 125 (02) : 766 - 772
  • [28] A homologous radioimmunoassay for rat insulin-like growth factor-I (IGF-I): Implications for studies of human IGF-I physiology
    Lee, PDK
    Baker, BK
    Liu, F
    Kwan, EYW
    Hintz, RL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05): : 2002 - 2005
  • [29] INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND ESPECIALLY IGF-I VARIANTS ARE ANABOLIC IN DEXAMETHASONE-TREATED RATS
    TOMAS, FM
    KNOWLES, SE
    OWENS, PC
    CHANDLER, CS
    FRANCIS, GL
    READ, LC
    BALLARD, FJ
    BIOCHEMICAL JOURNAL, 1992, 282 : 91 - 97
  • [30] Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism
    Wilson, ME
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11): : 4013 - 4021